Otsuka Holdings Co., Ltd. (4578) - Financial and Strategic SWOT Analysis Review

Date: March 22, 2016
Pages: 51
Price:
US$ 300.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O0EFA7DA433EN
Leaflet:

Download PDF Leaflet

Otsuka Holdings Co., Ltd. (4578) - Financial and Strategic SWOT Analysis Review
Otsuka Holdings Co., Ltd. (4578) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Otsuka Holdings Co., Ltd. (Otsuka) is a holding company, which operates various businesses such as pharmaceuticals, nutraceuticals, consumer products and other businesses through its subsidiaries. It focuses on the research and development, manufacture, and sale of medicines for the treatment of cancer, cardiovascular diseases, central nervous system disorders, ophthalmic diseases, gastrointestinal and respiratory diseases, infectious diseases, dermatological conditions and allergies, among others. The company’s product portfolio includes pharmaceutical products, cosmetics, functional foods and beverages, alcoholic beverages, fine chemicals, electronic equipment, functional chemicals, medical devices and OTC products. It markets its products in North America, Europe and Asia. Otsuka is headquartered in Chiyoda-ku, Tokyo, Japan.

Otsuka Holdings Co., Ltd. Key Recent Developments

Aug 07, 2015: Otsuka Holdings Company Reports Net Sales Of JPY745.8 Billion In H1 2015
May 13, 2015: Otsuka Holdings Company Reports Net Sales Of JPY385.1 Billion In Q1 2015
Apr 10, 2015: Otsuka announces 2015 first quarter U.S. net sales figures of ABILIFY
Mar 27, 2015: Otsuka Holdings Announces Change in Status of Representative Director
Feb 13, 2015: Otsuka Holdings Announces Personnel Change of Representative Director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Otsuka Holdings Co., Ltd. - Key Facts
Otsuka Holdings Co., Ltd. - Key Employees
Otsuka Holdings Co., Ltd. - Major Products and Services
Otsuka Holdings Co., Ltd. - Pharmaceutical Pipeline Products Data
Otsuka Holdings Co., Ltd., Pipeline Products by Therapy Area
Otsuka Holdings Co., Ltd., Pipeline Products by Development Phase
Otsuka Holdings Co., Ltd. - History
Otsuka Holdings Co., Ltd. - Company Statement
Otsuka Holdings Co., Ltd. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate

SECTION 2 – COMPANY ANALYSIS

Otsuka Holdings Co., Ltd. - Business Description
Otsuka Holdings Co., Ltd. - Corporate Strategy
Otsuka Holdings Co., Ltd. - SWOT Analysis
SWOT Analysis - Overview
Otsuka Holdings Co., Ltd. - Strengths
Strength - Core Business: Pharmaceuticals Business
Strength - Operational Network
Strength - Research Expertise
Otsuka Holdings Co., Ltd. - Weaknesses
Weakness - Loss of Exclusivity: Abilify
Weakness - Weak Operational Performance
Weakness - Product Discontinuations
Otsuka Holdings Co., Ltd. - Opportunities
Opportunity - Inorganic Growth Strategies
Opportunity - Late Stage Development
Opportunity - Product Approvals and Launches
Otsuka Holdings Co., Ltd. - Threats
Threat - Competitive Landscape
Threat - Stringent Regulations
Threat - Rapid Technological Change
Otsuka Holdings Co., Ltd. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Otsuka Holdings Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Otsuka Holdings Co., Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Otsuka Holdings Co., Ltd., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 07, 2015: Otsuka Holdings Company Reports Net Sales Of JPY745.8 Billion In H1 2015
May 13, 2015: Otsuka Holdings Company Reports Net Sales Of JPY385.1 Billion In Q1 2015
Apr 10, 2015: Otsuka announces 2015 first quarter U.S. net sales figures of ABILIFY
Mar 27, 2015: Otsuka Holdings Announces Change in Status of Representative Director
Feb 13, 2015: Otsuka Holdings Announces Personnel Change of Representative Director
Feb 13, 2015: Otsuka Holdings Company Reports Net Sales Of JPY1.22 Trillion For Nine Months Ended December 31, 2014

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Otsuka Holdings Co., Ltd., Key Facts
Otsuka Holdings Co., Ltd., Key Employees
Otsuka Holdings Co., Ltd., Major Products and Services
Otsuka Holdings Co., Ltd., Number of Pipeline Products by Therapy Area
Otsuka Holdings Co., Ltd., Number of Pipeline Products by Development Stage
Otsuka Holdings Co., Ltd., Pipeline Products By Therapy Area and Development Phase
Otsuka Holdings Co., Ltd., History
Otsuka Holdings Co., Ltd., Other Locations
Otsuka Holdings Co., Ltd., Subsidiaries
Otsuka Holdings Co., Ltd., Affiliate
Otsuka Holdings Co., Ltd., Key Competitors
Otsuka Holdings Co., Ltd., Ratios based on current share price
Otsuka Holdings Co., Ltd., Annual Ratios
Otsuka Holdings Co., Ltd., Interim Ratios
Otsuka Holdings Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Otsuka Holdings Co., Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Otsuka Holdings Co., Ltd., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Otsuka Holdings Co., Ltd., Pipeline Products by Therapy Area
Otsuka Holdings Co., Ltd., Pipeline Products by Development Phase
Otsuka Holdings Co., Ltd., Performance Chart (2011 - 2015)
Otsuka Holdings Co., Ltd., Ratio Charts
Otsuka Holdings Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Otsuka Holdings Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Skip to top


Gastric Cancer Global Clinical Trials Review, H2, 2015 US$ 2,000.00 Aug, 2015 · 179 pages

Ask Your Question

Otsuka Holdings Co., Ltd. (4578) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: